Figure 6From: Histopathological grading of pediatric ependymoma: reproducibility and clinical relevance in European trial cohortsPercentages of tumors from the CNS9204 cohort for which each neuropathologist's independent grade assignment (phase 1) matched the consensus grade after joint review by all pathologists (phase 2); e.g. pathologist A independently classified 22/84 tumors as grade II and 62/84 tumors as grade III during phase 1, while in phase 2, joint review classified 17/22 and 54/62 as grade II and grade III tumors, respectively, producing an overall "match" on 71/84 tumors.Back to article page